Search Results - "Meredith, Ken Lee"

Redefining the learning curve for robotic esophagectomy by Meredith, Ken Lee, Huston, Jamie, Briceno, Pedro, Shridhar, Ravi

“…Abstract only 132 Background: Minimally invasive esophagectomy(MIE) has demonstrated superior outcomes compared to open approaches. The myriad of techniques…”
Get full text

Effect of adjuvant radiation on survival for extra-hepatic cholangiocarcinoma by Takahashi, Caitlin, Shridhar, Ravi, Huston, Jamie, Patel, Anjan Jayantilal, Brown, Richard H., Koehler, Kevin, Briceno, Pedro, Meredith, Ken Lee

“…Abstract only 377 Background: Extra-hepatic cholangiocarcinomas (EHC) are low-incidence cancers that are difficult to diagnose and associated with a dismal…”
Get full text

Adjuvant therapy for margin positive pancreatic cancer by Takahashi, Caitlin, Shridhar, Ravi, Harris, Cynthia L., Lee, Justin, Patel, Anjan Jayantilal, Brown, Richard H., Huston, Jamie, Kucera, Stephen, Meredith, Ken Lee

“…Abstract only 390 Background: Pancreatic cancer continues to have a dismal prognosis despite improvements in surgical care. Approximately 26% of patients are…”
Get full text

Trans-intra-arterial gemcitabine versus continuation of IV gemcitabine and nab-paclitaxel following radiotherapy for locally advanced pancreatic cancer (TIGeR-PaC) by Pishvaian, Michael J., Goodman, Karyn A., Zervos, Emmanuel E., Muscarella, Peter, Kim, Alexander Y., Bloomston, Mark, Nutting, Charles W., Meredith, Ken Lee, Lavu, Harish, Chuy, Jennifer W., Lee, Justin, Matrana, Marc Ryan, Lavarias, Clifford, Gellert, Scott, Agah, Ramtin

“…Abstract only TPS529 Background: Treatment of locally advanced pancreatic cancer (LAPC) remains a challenge, and novel therapy options for local treatment of…”
Get full text

Outcomes in patients with brain metastasis from esophageal carcinoma by Saeed, Nadia, Kothari, Nishi, Mellon, Eric Albert, Hoffe, Sarah E., Frakes, Jessica M., Shridhar, Ravi, Pimiento, Jose Mario, Meredith, Ken Lee, Tran, Nam D., Almhanna, Khaldoun

“…Abstract only 159 Background: Brain metastases from esophageal carcinoma have historically been rare. With improvements in systemic therapy, patients are…”
Get full text